Zealand Pharma — Director's Dealing 2021

Sep 7, 2021

FINANSTILSYNET

Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.	Details of the person discharging managerial responsibilities/person closely associated
a)	Name	Louise Gjelstrup
2.	Reason for the notification
a)	Position/status	Employee elected member of the Board of Directors of Zealand Pharma A/S
b)	Initial notification/Amendment	Initial notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Zealand Pharma A/S, CVR-no. 20045078
b)	LEI¹	549300ITBB1ULBL4CZ12
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument	Shares
	Identification code	DK0060257814
b)	Nature of the transaction	Sale of Shares
c)	Price(s) and volume(s)	Price(s)	Volume(s)
		DKK 203,4	835
d)	Aggregated information
- Aggregated volume
- Price	DKK 169.839
e)	Date of the transaction	06 September 2021
f)	Place of the transaction	Nasdaq Copenhagen A/S